Atezolizumab for the First-Line Treatment of Non-small Cell Lung Cancer (NSCLC): Current Status and Future Prospects.

Ryu, Rachel; Ward, Kristina E

Ryu, Rachel; Ward, Kristina E.

Afiliação

Ryu R; Department of Pharmacy Practice, College of Pharmacy, University of Rhode Island, Kingston, RI, United States.
Ward KE; Department of Pharmacy Practice, College of Pharmacy, University of Rhode Island, Kingston, RI, United States.

Front Oncol ; 8: 277, 2018.

Article em En | MEDLINE | ID: mdl-30087855

Palavras-chave

adenocarcinoma; immunotherapy; large cell carcinoma; non-small cell lung cancer; squamous cell cancer; targeted therapy

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Systematic_reviews Idioma: En Revista: Front Oncol Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google